12.27
-0.64 (-4.96%)
| Penutupan Terdahulu | 12.91 |
| Buka | 13.03 |
| Jumlah Dagangan | 977,131 |
| Purata Dagangan (3B) | 1,152,673 |
| Modal Pasaran | 546,772,032 |
| Harga / Jualan (P/S) | 4.90 |
| Harga / Buku (P/B) | 2.02 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 21 Apr 2026 |
| Margin Keuntungan | -101.62% |
| Margin Operasi (TTM) | -105.69% |
| EPS Cair (TTM) | -1.64 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 36.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2.22% |
| Nisbah Semasa (MRQ) | 15.88 |
| Aliran Tunai Operasi (OCF TTM) | -56.10 M |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | Beta Bionics, Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.63 |
|
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 6.51% |
| % Dimiliki oleh Institusi | 98.41% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 25.00 (Truist Securities, 103.75%) | Beli |
| Median | 22.00 (79.30%) | |
| Rendah | 14.00 (Baird, 14.10%) | Pegang |
| Purata | 20.33 (65.69%) | |
| Jumlah | 2 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 13.64 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Baird | 18 Feb 2026 | 14.00 (14.10%) | Pegang | 13.61 |
| Stifel | 18 Feb 2026 | 22.00 (79.30%) | Beli | 13.61 |
| 04 Feb 2026 | 25.00 (103.75%) | Beli | 14.09 | |
| Truist Securities | 02 Feb 2026 | 25.00 (103.75%) | Beli | 13.70 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |